From: Mucormycosis in renal transplant recipients: review of 174 reported cases
Variable | OR (95% CI) | P |
---|---|---|
Extent of infection | ||
Localized | Reference | |
Disseminated | 5.41(2.04–14.37) | 0.001 |
Organism | ||
Rhizopus spp. | Reference | |
Other organisms | >0.1 | |
Diabetes | ||
No | Reference | |
Diabetes | 0.43(0.20–0.89) | 0.02 |
Antifungal therapy | ||
None | Reference | |
Amphotericin B deoxycholate | 0.30 (0.09–0.97) | 0.04 |
Lipid amphotericin B | 0.10(0.03–0.33) | <0.001 |
Posaconazole alone and combined with other antifungals | 0.02(0.00–0.22) | <0.01 |
Surgery | ||
Surgery as primary therapy | Reference | |
Without surgery therapy | 5.83(2.68–12.70) | <0.001 |